Two people die and five missing after boat collision in Hungary
- 72
Police say two people have died and five are missing following a boat collision on the Danube River in Hungary. READ MORE ...
Euronews
Welcome to the official Euronews YouTube channel!
Around the clock, our team of 500 journalists of more than 30 different nationalities gathers news with impartial perspective, beyond the headlines content and voices from across Europe and the world. Our YouTube channel has all this and more, bringing you selected and original content from the world's most trusted news source.
Our mission is to empower people to form their own opinion. We trust in people’s intelligence and ability to make up their own mind and seek to provide our audience with the greatest diversity of viewpoints through journalism that is unapologetically impartial. We don’t trade in bias and outrage, we focus on facts, ideas, and solutions. We believe all views matter.
Euronews was born out of a will to create a strong independent European news channel in 1993. As the only international news media with a European perspective, Euronews is where the world turns to hear what Europe has to say.
Check us out on ⬇️
Lastest news
- EQS-Adhoc: Vulcan Energy Resources Limited: Vulcan Energy signs agreements with CIMIC Group, Hancock Prospecting and Victor Smorgon Group for a total equity investment of EUR 40 million
- Linker Vision to Accelerate Vision AI Adoption Across Enterprise Applications with Large Vision Models, in Collaboration with NVIDIA
- Seer Technology Access Center Provides Unprecedented Scale and Depth of Coverage for PrognomiQ’s Early Cancer Detection Study
- Boomco (BOOM) Is Now Available for Trading on LBank Exchange
- ALX Oncology Presents First Evorpacept Combination Data with an Antibody-Drug Conjugate from Phase 1 ASPEN-07 Clinical Trial in Patients with Advanced Bladder Cancer
- Nanobiotix Announces New Data Showing Disease Control and Tumor Response in Patients Treated With RT-Activated NBTXR3 Followed By anti-PD-1 For 2l+ R/M HNSCC Naïve or Resistant to Prior anti-PD-1 Therapy